Print
Erica Warlick, MD
Erica Warlick, MD
Request Appointment
Blood and Marrow Transplant Clinic
Phillips-Wangensteen Building
Fifth Floor, Clinic 5B
516 Delaware St. SE
Minneapolis, MN 55455
612-273-2800
 

Philosophy of Care:

With the increasing complexity of medical care, I believe that patient education is crucial for successful treatment and a successful patient-doctor relationship. My approach is to provide patients with information to understand their disease process and treatment options in an honest, thorough, and caring manner tailoring those treatment options to patient's goals of care.

Medical Title:

Academic Appointments:

Specialties:

Clinical Interests:

Languages Spoken:

Education:

Board Certifications:

Research Interests:

  • Alpha Omega Alpha
  • Champion of Care, Fairview: Patient Recognition 2012
  • de Latour RP, Brunstein CG, Porcher R, Chevallier P, Robin M, Warlick E, Xhaard A, Ustun C, Larghero J, Dhedin N, Mohty M, Socié G, Weisdorf D. Similar Overall Survival Using Sibling, Unrelated Donor, and Cord Blood Grafts after Reduced-Intensity Conditioning for Older Patients with Acute Myelogenous Leukemia. Biol Blood Marrow Transplant. 2013 Jun 18. doi:pii: S1083-8791(13)00253-X. 10.1016/j.bbmt.2013.06.006. [Epub ahead of print] PMID: 23791622
  • Wiernik A, Foley B, Zhang B, Verneris MR, Warlick E, Gleason MK, Ross JA, Luo X, Weisdorf DJ, Walcheck B, Vallera DA, Miller JS. Targeting Natural Killer Cells to Acute Myeloid Leukemia In Vitro with a CD16x33 Bispecific Killer Cell Engager and ADAM17 Inhibition. Clin Cancer Res. 2013 Jun 18. [Epub ahead of print]. PMID: 23690482
  • Warlick ED, Cao Q, Miller J. Bortezomib and vorinostat in refractory acute myelogenous leukemia and high-risk myelodysplastic syndromes: produces stable disease but at the cost of high toxicity. Leukemia. 2013 Feb 28. doi: 10.1038/leu.2013.61. [Epub ahead of print] No abstract available. PMID:23446311
  • Warlick E, Ahn KW, Pedersen TL, Artz A, de Lima M, Pulsipher M, Akpek G, Aljurf M, Cahn JY, Cairo M, Chen YB, Cooper B, Deol A, Giralt S, Gupta V, Khoury HJ, Kohrt H, Lazarus HM, Lewis I, Olsson R, Pidala J, Savani BN, Seftel M, Socié G, Tallman M, Ustun C, Vij R, Vindeløv L, Weisdorf D. Reduced intensity conditioning is superior to nonmyeloablative conditioning for older chronic myelogenous leukemia patients undergoing hematopoietic cell transplant during the tyrosine kinase inhibitor era. Blood. 2012 Apr 26;119(17):4083-90. doi: 10.1182/blood-2012-02-409763. Epub 2012 Mar 9. PMID:22408257
  • Warlick ED, DeFor T, Blazar BR, Burns L, Verneris MR, Ustun C, Weisdorf DJ, Miller JS. Successful remission rates and survival after lymphodepleting chemotherapy and donor lymphocyte infusion for relapsed hematologic malignancies postallogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2012 Mar;18(3):480-6. PMID: 22155141
  • Warlick E, Ahn KW, Pedersen TL, Artz A, de Lima M, Pulsipher M, Akpek G, Aljurf M, Cahn JY, Cairo M, Chen YB, Cooper B, Deol A, Giralt S, Gupta V, Khoury HJ, Kohrt H, Lazarus HM, Lewis I, Olsson R, Pidala J, Savani BN, Seftel M, Socié G, Tallman M, Ustun C, Vij R, Vindeløv L, Weisdorf D. Reduced intensity conditioning is superior to nonmyeloablative conditioning for older chronic myelogenous leukemia patients undergoing hematopoietic cell transplant during the tyrosine kinase inhibitor era. Blood. 2012 Apr 26;119(17):4083-90. PMID: 22408257
  • Warlick ED, Miller JS. Myelodysplastic syndromes: the role of the immune system in pathogenesis. Leuk Lymphoma. 2011 Jun 12. [Epub ahead of print]
  • Majhail NS, Brunstein CG, Shanley R, Sandhu K, McClune B, Oran B, Warlick ED, Wagner JE, Weisdorf DJ. Reduced-intensity hematopoietic cell transplantation in older patients with AML/MDS: umbilical cord blood is a feasible option for patients without HLA-matched sibling donors. Bone Marrow Transplant. 2011 May 23. [Epub ahead of print]
  • Majhail NS, Warlick ED. To cry or not to cry: physicians and emotions at the bedside. Minn Med. 2011 Jan;94(1):40-2.
  • Warlick ED. Epidemiology of myelodysplastic syndromes: many questions remain. Leuk Lymphoma. 2011 Feb;52(2):163-4.
  • McCormack SE, Cao Q, Oran B, Weisdorf DJ, Warlick ED. Pre-transplant consolidation chemotherapy may not improve outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission. Leuk Res. 2011 Jan 11. [Epub ahead of print]
 
 Visit Other Fairview Sites 
 
 
(c) 2012 Fairview Health Services. All rights reserved.